• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 与免疫:何去何从?

COVID-19 and immunity: quo vadis?

机构信息

Immunology Frontier Research Center (IFReC), Osaka University, 3-3-1, Yamada-oka, Suita 565-0871, Japan.

出版信息

Int Immunol. 2021 Sep 25;33(10):507-513. doi: 10.1093/intimm/dxab008.

DOI:10.1093/intimm/dxab008
PMID:33569606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7928925/
Abstract

Understanding the precise nature and durability of protective immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential in order to gain insight into the pathophysiology of coronavirus disease 2019 (COVID-19) and to develop novel treatment strategies to this disease. Here, I succinctly summarize what is currently known and unknown about the immune response during COVID-19 and discuss whether natural infections can lead to herd immunity.

摘要

了解针对严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的保护性免疫的确切性质和持久性对于深入了解 2019 年冠状病毒病(COVID-19)的病理生理学以及开发针对这种疾病的新型治疗策略至关重要。在这里,我简明扼要地总结了目前已知和未知的 COVID-19 期间的免疫反应,并讨论了自然感染是否可以导致群体免疫。

相似文献

1
COVID-19 and immunity: quo vadis?COVID-19 与免疫:何去何从?
Int Immunol. 2021 Sep 25;33(10):507-513. doi: 10.1093/intimm/dxab008.
2
Contact-adjusted Immunity Levels against SARS-CoV-2 in Korea and Prospects for Achieving Herd Immunity.韩国针对 SARS-CoV-2 的接触调整免疫水平和实现群体免疫的前景。
J Korean Med Sci. 2021 Oct 4;36(38):e272. doi: 10.3346/jkms.2021.36.e272.
3
Individuals cannot rely on COVID-19 herd immunity: Durable immunity to viral disease is limited to viruses with obligate viremic spread.个体不能依赖新冠病毒群体免疫:对病毒性疾病的持久免疫力仅限于具有专性病毒血症传播的病毒。
PLoS Pathog. 2021 Apr 26;17(4):e1009509. doi: 10.1371/journal.ppat.1009509. eCollection 2021 Apr.
4
Herd immunization with childhood vaccination may provide protection against COVID-19.群体免疫接种儿童疫苗可能对预防 COVID-19 提供保护。
Acta Microbiol Immunol Hung. 2020 Sep 26;67(3):198-200. doi: 10.1556/030.2020.01207.
5
How to Understand Herd Immunity in the Context of COVID-19.如何理解 COVID-19 大流行中的群体免疫。
Viral Immunol. 2021 Apr;34(3):174-181. doi: 10.1089/vim.2020.0195. Epub 2020 Dec 21.
6
COVID-19 vaccines and herd immunity: Perspectives, challenges and prospects.COVID-19 疫苗与群体免疫:观点、挑战与展望。
Malays J Pathol. 2021 Aug;43(2):203-217.
7
Results from a survey in healthy blood donors in South Eastern Italy indicate that we are far away from herd immunity to SARS-CoV-2.意大利东南部健康献血者的调查结果表明,我们离对 SARS-CoV-2 获得群体免疫还很遥远。
J Med Virol. 2021 Mar;93(3):1739-1742. doi: 10.1002/jmv.26425. Epub 2020 Aug 26.
8
Could COVID-19 be contained in poor populations by herd immunity rather than by strategies designed for affluent societies or potential vaccine(s)?新冠病毒肺炎能否通过群体免疫而非为富裕社会或潜在疫苗设计的策略在贫困人口中得到控制?
Glob Health Action. 2021 Jan 1;14(1):1863129. doi: 10.1080/16549716.2020.1863129.
9
Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases.微生物组的影响:针对病毒病不断发展群体免疫的范例。
Viruses. 2020 Oct 10;12(10):1150. doi: 10.3390/v12101150.
10
Immunopathogenesis and immunobiology of SARS-CoV-2.SARS-CoV-2 的免疫发病机制和免疫生物学。
Infez Med. 2021 Jun 1;29(2):167-180.

引用本文的文献

1
The lymphatic system and COVID-19 vaccines.淋巴系统与 COVID-19 疫苗。
Front Immunol. 2022 Oct 20;13:1041025. doi: 10.3389/fimmu.2022.1041025. eCollection 2022.
2
Disparities in the Evolution of the COVID-19 Pandemic between Spanish Provinces.西班牙各省 COVID-19 大流行演变的差异。
Int J Environ Res Public Health. 2021 May 11;18(10):5085. doi: 10.3390/ijerph18105085.
3
Anti-SARS-CoV-2 vaccination strategy for pregnant women in Japan.日本针对孕妇的抗 SARS-CoV-2 疫苗接种策略。
J Obstet Gynaecol Res. 2021 Jun;47(6):1958-1964. doi: 10.1111/jog.14748. Epub 2021 Mar 23.